24 Dec 2020  |  North America
Breakthrough Innovations in Transcranial Electrical Stimulation, Transcranial Magnetic Stimulation, Cranial Electrotherapy Stimulation and other Non-invasive Neuromodulation Therapies Bolstering the Psychiatric Toolbox
The treatment of mental health disorders using pharmaceuticals and psychotherapy are plagued with limitations such as therapy-related adverse effects, and inability to provide effective remission. This has driven the use of neuromodulation techniques for managing these conditions. However, these traditional neuromodulation therapies have their shar...
29 Nov 2019  |  Global
Innovations in Imaging Technologies, Drug Delivery Solutions, Diagnostic and Neuromodulation Devices
The latest issue of Advanced MedTech TechVision Opportunity Engine (TOE) profiles a wide variety of medical devices and imaging innovations across the globe. The innovations span the breadth of market segments in the medtech space, from advanced imaging technologies, to drug delivery technologies, smart phone enabled diagnostics, and neuromodulatio...
USD 855.00 save 10 %
16 Feb 2018  |  Global
Innovations in Neuromodulation, Connected Health, Microneedles, Telemedicine, and Advanced Orthopedic Implants
The latest edition of Medical Device TOE profiles diverse innovations from the advanced medical technology ecosystem. These include a neuromodulation system to manage chronic pain and muscular disorders, a remote patient monitoring system to manage heart conditions, and a compact proton beam therapy that promises more accurate radiation therapy in...
USD 712.50 save 25 %
03 Feb 2017  |  Global
This edition of FT TOE covers technological developments and commercial implications of various neuromodulation therapies that are redefining the standard of care offered by traditional drug-based therapies. The issue covers a snapshot of the global neuromodulation industry, highlighting the intensity of research and commercial prospects for newer ...
USD 562.50 save 25 %
24 Feb 2016  |  Global
Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. Thi...
USD 3,712.50 save 25 %